Moderna
Евгения Матвеец/Getty Images (NEW YORK) — Moderna announced Tuesday it has dosed its first participant in a phase III clinical trial of a combination influenza and COVID-19 vaccine. This phase will evaluate the safety and efficacy of the combo vaccine compared to flu and COVID vaccines that are administered separately in two groups, one involving […]
Artur Widak/NurPhoto via Getty Images (NEW YORK) — Moderna will keep its COVID vaccine on the market at no cost to consumers, even after the federal government stops paying for it, the company announced Wednesday. “Everyone in the United States will have access to Moderna’s COVID-19 vaccine regardless of their ability to pay,” the company […]
Nikos Pekiaridis/NurPhoto via Getty Images (NEW YORK) — Moderna’s respiratory syncytial virus, or RSV, vaccine for older adults was about 84% effective at preventing serious illness, according to data from a late-stage trial published Tuesday. Adult patients in the clinical trial appeared to tolerate the vaccine well and there were no safety concerns identified, the […]
-
Pages